News and Features Related to Multiple Sclerosis
-
Survey Reveals Economic Toll of MS
May 25, 2010 -- All over the world, of the people who quit working due to multiple sclerosis (MS), almost half did so within three years of being diagnosed with the debilitating disease, a new survey shows. The Multiple Sclerosis International Federation surveyed people with MS in 125 countries. The
Read Full Article -
Multiple Sclerosis: Advances in Research and Treatment
While the cause of multiple sclerosis (MS) is still not known, advances in treatment options and new understanding about the disease have been especially brisk in the past few years, researchers say. As a result, the future for the 400,000 Americans with the chronic, sometimes disabling disease may
Read Full Article -
Caution Urged for Experimental MS Treatment
April 19, 2010 (Toronto) -- People with multiple sclerosis (MS) should not undergo a controversial new treatment that's based on the theory that blocked neck veins can trigger MS, experts say. Neither the theory nor the treatment -- using angioplasty to open up the narrowed veins -- has been proved
Read Full Article -
Statin Drugs May Help Treat MS
April 15, 2010 (Toronto) -- Statin drugs show promise for the treatment of multiple sclerosis (MS), a small, preliminary study suggests. Statin drugs are best known for their cholesterol-lowering effects. But the drugs "have anti-inflammatory effects on immune cells as well, which is why we figured
Read Full Article -
Experimental MS Drug Outperforms Standard Treatment
April 15, 2010 (Toronto) -- Nearly 71% of people with early relapsing-remitting multiple sclerosis (MS) treated with the experimental MS drug alemtuzumab showed no evidence of disease activity four years into a study, researchers report. That's twice the percentage of patients treated with the appr
Read Full Article -
2 Types of MS, Study Reveals
March 29, 2010 - New study findings may soon revolutionize multiple sclerosis (MS) treatment and diagnosis. The study strongly suggests that there are two major types of MS and that a simple blood test can tell one from the other. By itself, that would be a major finding. But that's not all. One typ
Read Full Article -
Clay Walker Strums Up Funds for Multiple Sclerosis
When guitar picker Clay Walker lost coordination in his right hand while playing basketball with friends in 1996, the Texan was justifiably nervous. "At first I was kind of laughing about it," he recalls. "But then I started having double vision and dizziness, and I couldn't stand up. And I realized
Read Full Article -
MS Drug Ampyra Gets FDA Nod
Jan. 22, 2010 - The FDA has approved Ampyra (dalfampridine), which improves walking ability in adults with multiple sclerosis (MS). About three-fourths of MS patients have trouble walking, and 70% of those with walking problems say this is the most challenging aspect of their disease. Ampyra is take
Read Full Article -
New Oral MS Drugs May Be on the Horizon
Jan. 20, 2010 -- Two new drugs for multiple sclerosis, both taken orally, reduce the rates of relapses in multiple sclerosis patients -- sometimes keeping 80% or more of patients relapse-free during the study period -- according to new research. The new drugs, if approved, promise an end to injectio
Read Full Article -
Marijuana Eases Spasticity in MS Patients
Dec. 4, 2009 -- Marijuana extracts may reduce spasticity symptoms in people with multiple sclerosis, a new study shows. The review, by Shaheen Lakhan, PhD, and Marie Rowland, PhD, of the Global Neuroscience Initiative Foundation in Los Angeles, found that five of six published studies they analyzed
Read Full Article
Today in Multiple Sclerosis
WebMD Special Sections
Health Solutions From Our Sponsors
©2005-2013 WebMD, LLC. All rights reserved.
WebMD does not provide medical advice, diagnosis or treatment. See additional information.